Your browser doesn't support javascript.
loading
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results.
Wein, Axel; Stoehr, Robert; Kersting, Stephan; Siebler, Jürgen; Merkel, Susanne; Busse, Dagmar; Wolff, Kerstin; Ostermeier, Nicola; Neufert, Clemens; Vitali, Francesco; Eckstein, Markus; Roth, Jan-Peter; Anhut, Peter; Schreiner, Waldemar; Uder, Michael; Hartmann, Arndt; Neurath, Markus F; Grützmann, Robert.
Afiliação
  • Wein A; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Stoehr R; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Kersting S; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Siebler J; Department of Surgery, University of Greifswald, Greifswald, Germany.
  • Merkel S; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Busse D; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Wolff K; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Ostermeier N; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Neufert C; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Vitali F; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Eckstein M; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Roth JP; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Anhut P; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Schreiner W; Medical Practice of Oncology, Kronach, Germany.
  • Uder M; Department of Surgery, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Hartmann A; Department of Radiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Neurath MF; Department of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Grützmann R; Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Oncology ; 100(1): 1-11, 2022.
Article em En | MEDLINE | ID: mdl-34670215
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha